Causative factors of deep vein thrombosis of lower limb in Indian population
DOI:
https://doi.org/10.18203/2349-2902.isj20175919Keywords:
Deep venous thrombosis, Immobility, ThrombusAbstract
Background: Deep vein thrombosis refers to the formation of an abnormal coagulum within the deep venous system. An accurate diagnosis of DVT is extremely important to prevent potentially fatal acute complications of pulmonary embolism (PE) and long-term complications of post phlebitis syndrome and pulmonary hypertension. There are many causative factors for DVT.
Methods: This was a prospective study where 50 cases of DVT were admitted in this centre. Patients were evaluated in terms of causative factors of DVT. These were previous history of DVT, immobility, surgery, smoking, obesity and drugs. Age and gender comparisons were also done. The most common causes were recorded.
Results: The most common cause was found to be immobility and post-surgery immobilization which constituted 90 % of the patients in the study. Advanced age and male gender showed a higher incidence of DVT.
Conclusions: Early identification of the causes and the risk factors in the development of DVT can reduce the burden of the disease and contribute to its prevention and management.
Metrics
References
Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation. 1996;93(12):2212-45.
Silverstein MD, Heit JA, Mohr DN. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585-93.
Wendelboe AM, McCumber M, Hylek EM, Buller H, Weitz JI, Raskob G, ISTH Steering Committee for World Thrombosis Day. Global public awareness of venous thromboembolism. J Thromb Haemost. 2015;13:1365-71.
Quriel K, Green RM, Greenber GRK, Clair DG. Annual Meeting of the Midwesten Vasucular Surgical Society. J of Vascular Surgery. 2000;31:895-900.
Parasuraman S, Goldhaber SZ. Venous thromboembolism in children. Circulation. 2006;113:e12-e16.
Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692-9.
Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med. 2004;350(25):2558-63.
Tapson VF, Carroll BA, Davidson BL. The Diagnostic Approach to Acute Venous Thromboembolism. Clinical Practice Guideline. American Thoracic Society. Am J Respir Crit Care Med. 1999;160(3):1043-66.
Kahn SR. The clinical diagnosis of deep vein thrombosis: integrating incidence, risk factors and symptoms and signs. Arch Intern Med. 1998;158(21):2315-23.
Hillen HFP. Thrombosis in cancer patients. Annals of Oncology. 2000;11(3):273-6.
Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715-22.
Vandenbroucke JP, Rosing J, Bloemenkamp KW. Oral contraceptives and the risk of venous thrombosis. N Engl J Med. 2001;344:1527-35.
Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S.The Risk of Recurrent Venous Thromboembolism in Men and Women.N Engl J Med. 2004;350:2558-63.
Schulman S, Granqvist S, Holmstrom M. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med. 1997;336:393-8.
Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: part 1. Thromb Haemost. 1996;76:651-62.
Bezemer ID, van der Meer FJ, Eikenboom JC, Rosendaal FR, Doggen CJ. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med. 2009;169:610-5.
Pintao MC, Ribeiro DD, Bezemer ID, Garcia AA, de Visser MC, Doggen CJ, et al. Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study. Blood. 2013;122:3210-9.